Literature DB >> 26200674

New Family With Catecholaminergic Polymorphic Ventricular Tachycardia Linked to the Triadin Gene.

Caroline Rooryck1,2,3, Florence Kyndt4, Dominique Bozon5, Nathalie Roux-Buisson6, Frederic Sacher2, Vincent Probst4, Jean-Benoit Thambo2,3.   

Abstract

We describe a new family with cathecholaminergic polymorphic ventricular tachycardia (CPVT) linked to the Triadin gene. This is the second report of such a CPVT of autosomal recessive inheritance. Using an NGS panel including 42 genes involved in cardiac sudden death, 2 heterozygous pathogenic mutations (c.613C> T/p.Gln205* and c.22 + 29 A>G) were identified in the Triadin gene in 2 sibs who experienced early severe arrhythmias without evidence of CPVT diagnosis at first cardiac evaluation. However, significant arrhythmias occurred after catecholaminergic stimulation. Each of the TRDN mutations was inherited from a healthy parent. In this family, genetic studies permit confirmation of the CPVT diagnosis in the 2 affected sibs and permit the early diagnosis of the third asymptomatic child. It also helped guide the therapeutic strategy in this family.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  catecholaminergic polymorphic ventricular tachycardia; genetic arrhythmias; presymptomatic testing; sudden cardiac death; triadin

Mesh:

Substances:

Year:  2015        PMID: 26200674     DOI: 10.1111/jce.12763

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  14 in total

1.  Interplay between Triadin and Calsequestrin in the Pathogenesis of CPVT in the Mouse.

Authors:  Marine Cacheux; Jérémy Fauconnier; Jérôme Thireau; Alexis Osseni; Jacques Brocard; Nathalie Roux-Buisson; Julie Brocard; Julien Fauré; Alain Lacampagne; Isabelle Marty
Journal:  Mol Ther       Date:  2019-09-13       Impact factor: 11.454

Review 2.  Using iPSC Models to Probe Regulation of Cardiac Ion Channel Function.

Authors:  Arne A N Bruyneel; Wesley L McKeithan; Dries A M Feyen; Mark Mercola
Journal:  Curr Cardiol Rep       Date:  2018-05-25       Impact factor: 2.931

3.  Ion Channel Diseases: an Update for 2016.

Authors:  Gordon F Tomaselli; Andreas S Barth
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-03

4.  Congenital myopathy associated with the triadin knockout syndrome.

Authors:  Andrew G Engel; Keeley R Redhage; David J Tester; Michael J Ackerman; Duygu Selcen
Journal:  Neurology       Date:  2017-02-15       Impact factor: 9.910

Review 5.  Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Vassilios J Bezzerides; Donghui Zhang; William T Pu
Journal:  Circ J       Date:  2016-12-03       Impact factor: 2.993

6.  Genetic Loss of IK1 Causes Adrenergic-Induced Phase 3 Early Afterdepolariz ations and Polymorphic and Bidirectional Ventricular Tachycardia.

Authors:  Louise Reilly; Francisco J Alvarado; Di Lang; Sara Abozeid; Hannah Van Ert; Cordell Spellman; Jarrett Warden; Jonathan C Makielski; Alexey V Glukhov; Lee L Eckhardt
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-08-04

Review 7.  Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Matthew J Wleklinski; Prince J Kannankeril; Bjӧrn C Knollmann
Journal:  J Physiol       Date:  2020-04-27       Impact factor: 5.182

8.  Catecholaminergic Polymorphic Ventricular Tachycardia - Looking to the Future.

Authors:  Andreea Elena Velcea; Calin Siliste; Dragos Vinereanu
Journal:  Maedica (Bucur)       Date:  2017-12

9.  Genomic-based diagnosis of arrhythmia disease in a personalized medicine era.

Authors:  Abdullah Omar; Mi Zhou; Adam Berman; Robert A Sorrentino; Neela Yar; Neal L Weintraub; Il-Man Kim; Wei Lei; Yaoliang Tang
Journal:  Expert Rev Precis Med Drug Dev       Date:  2016-12-02

Review 10.  Mechanisms underlying pathological Ca2+ handling in diseases of the heart.

Authors:  Satadru K Lahiri; Yuriana Aguilar-Sanchez; Xander H T Wehrens
Journal:  Pflugers Arch       Date:  2021-01-05       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.